EN
HI
Summary
As of 4 Oct, 2026, Glaxosmithkline Pharmaceuticals stock price is ₹2771.1. During the trading session, the stock has moved between an intraday low of ₹2724.80 and an intraday high of ₹2799.00. Over the last 52 weeks, Glaxosmithkline Pharmaceuticals has traded between ₹2088.10 and ₹3120.70.
The stock has recorded a trading volume of 73,407 shares,. Its Average Traded Price (ATP) is ₹2764.29, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2771.10.
Glaxosmithkline Pharmaceuticals has an upper circuit limit of ₹3325.30 and a lower circuit limit of ₹2216.90. The total value traded stands at ₹20.29 CR, and the delivery percentage for the day is 54.78%.
The stock is currently traded with a market lot size of 1. Glaxosmithkline Pharmaceuticals also offers a dividend yield of 2.05%.
Glaxosmithkline Pharmaceuticals Share Price Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
73407.00
Market Cap
46944.11 CR
LTQ@LTP
1@2771.10
ATP
2764.29
Var Margin
15.34 %
Circuit Range
2216.9-3325.3
Delivery %
54.78 %
Value
20.29 CR
ASM/GSM
No
Market Lot
1
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
44
P/B Ratio
18.65
Div. Yield
2.05
Sector P/E
42.73
Sector P/B
3.55
Sec. Div. Yield
0.52
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2778.33
Resistance
First Resistance
2804.56
Second Resistance
2839.83
Third Resistance
2866.06
Support
First Support
2743.06
Second Support
2716.83
Third Support
2681.56
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 2773.7 | 2771.1 | 0.06% | 2799 | 2724.8 |
| Wed Sep 30 2026 | 2783.8 | 2769.3 | -0.52% | 2813.6 | 2752.1 |
| Tue Sep 29 2026 | 2888 | 2783.8 | -3.89% | 2899.89 | 2770.6 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
GlaxoSmithKline Pharmaceuticals announced the outcome of its postal ballot. Shareholders approved the appointment of Ms. Karine J F Natland as Non-Executive Director and the re-appointment of Mr. Bhushan Akshikar as Managing Director with overwhelming support.
Sep 15 2026 12:49:29
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
GlaxoSmithKline Pharmaceuticals announced the outcome of its postal ballot. Shareholders approved the appointment of Ms. Karine J F Natland as Non-Executive Director and the re-appointment of Mr. Bhushan Akshikar as Managing Director with overwhelming support.
Sep 15 2026 12:47:40
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Abbott India Ltd.
26840.00
-285.00 (1.05%)
Gland Pharma Ltd.
2874.40
-25.00 (0.86%)
Ipca Laboratories Ltd.
1943.20
16.20 (0.84%)
Anthem Biosciences Ltd.
855.75
-2.85 (0.33%)
Ajanta Pharma Ltd.
3581.00
-39.80 (1.10%)
Global Health Ltd.
1357.30
-7.70 (0.56%)
Emcure Pharmaceuticals Ltd.
1944.60
1.60 (0.08%)
Narayana Hrudayalaya Ltd.
1741.40
-50.00 (2.79%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2771.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 44. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 18.65. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 46944.11 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3120.70 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLAXO
